Interestingly, altered hepatic expression of cle-CASP3 and CHOP by AMPK activators aligns strongly with the reduced gene expression we observed in VTE-treated NASH mouse livers. Here, DDIT3 is linked to metabolic dysfunction-associated steatohepatitis.